Laure Le Goff
Bron, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial.
Journal: Nature medicine
Published: January 28, 2026
Comparative Clinical Outcomes of Nusinersen and Gene Therapy in Spinal Muscular Atrophy Type 1.
Journal: JAMA network open
Published: October 08, 2025
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial.
Journal: Nature medicine
Published: July 23, 2025
Structural validity of the French version of the Child and Adolescent Scale of Participation (CASP-Fr) and factors influencing the participation of children with neuromuscular diseases.
Journal: Disability and rehabilitation
Published: January 30, 2025
Spectrum of Phenotypes in SMA Patients With 4 SMN2 Copies in the French Population: Registre SMA France.
Journal: Neurology. Genetics
Published: August 05, 2024
Real-world multidisciplinary outcomes of onasemnogene abeparvovec monotherapy in patients with spinal muscular atrophy type 1: experience of the French cohort in the first three years of treatment.
Journal: Orphanet journal of rare diseases
Published: May 09, 2023
Psychometric Characteristics of the Motor Function Measure in Neuromuscular Diseases: A Systematic Review1.
Journal: Journal of neuromuscular diseases
Published: May 01, 2023
Correction to: Use of MFM-20 to monitor SMA types 1 and 2 patients treated with nusinersen.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: November 23, 2022
Scoring People With Spinal Muscular Atrophy on the Motor Function Measure Using the Microsoft Kinect.
Journal: Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association
Published: October 26, 2022
Use of MFM-20 to monitor SMA types 1 and 2 patients treated with nusinersen.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: June 17, 2022
Psychomotor development of infants and children...
Journal: La Revue du praticien
Published: March 08, 2022
Psychomotor development in infants and children. Normal and pathological aspects ( sleep, diet, sphincter controls, psychomotricity)
Journal: La Revue du praticien
Published: February 11, 2022
Last Updated: 09/26/2026